Drug Profile
WQ 2743
Alternative Names: AT 7836; WQ-2743Latest Information Update: 08 Sep 2003
Price :
$50
*
At a glance
- Originator Wakunaga Pharmaceutical
- Developer Dainippon Pharmaceutical; Wakunaga Pharmaceutical
- Class Antibacterials; Quinolones
- Mechanism of Action Type II DNA topoisomerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 08 Sep 2003 Discontinued - Preclinical for Bacterial infections in Japan (unspecified route)
- 02 Jun 1998 Dainippon Pharmaceutical is a licensee
- 06 Jan 1998 Preclinical development for Bacterial infections in Japan (Unknown route)